| NCT ID | NCT03729232 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Cerebral and Cardiovascular Center, Japan |
| Condition | Catheter Ablation |
| Study Type | OBSERVATIONAL |
| Enrollment | 400,000 participants |
| Start Date | 2017-07-01 |
| Primary Completion | 2030-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400,000 participants in total. It began in 2017-07-01 with a primary completion date of 2030-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Japanese Cather Ablation (J-AB) Registry is a voluntary nationwide registry, performed by Japanese Heart Rhythm Society, collaborated with the National Cerebral and Cardiovascular Center. The objectives of this registry are to observe and describe developments in the catheter ablation treatment of arrhythmia in Japan and to provide reliable information on the type of activity performed and the facilities available in Japanese arrhythmia units.
Eligibility Criteria
Inclusion Criteria: * Patients treated with catheter ablation in Japan Exclusion Criteria: * Patients who refused to consent
Contact & Investigator
Teiichi Yamane, MD, PhD
PRINCIPAL INVESTIGATOR
The Jikei University School of Medicine
Frequently Asked Questions
Who can join the NCT03729232 clinical trial?
This trial is open to participants of all sexes, studying Catheter Ablation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03729232 currently recruiting?
Yes, NCT03729232 is actively recruiting participants. Contact the research team at kusanokengo@ncvc.go.jp for enrollment information.
Where is the NCT03729232 trial being conducted?
This trial is being conducted at Suita, Japan.
Who is sponsoring the NCT03729232 clinical trial?
NCT03729232 is sponsored by National Cerebral and Cardiovascular Center, Japan. The principal investigator is Teiichi Yamane, MD, PhD at The Jikei University School of Medicine. The trial plans to enroll 400,000 participants.